AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
a study on Stroke
Stroke Atrial Cardiopathy Cryptogenic stroke Ischemic stroke Apixaban Aspirin Heart Diseases
Lead Scientists at UCSF
- William Likosky, MD
William H. Likosky, M.D., FAAN, FAHA, attended the University of Vermont for both his undergraduate and medical school training, graduating cum laude. Dr. Likosky attended Yale University Hospitals for his Neurology residency and fellowship, and Medicine internship and residency.
- Karl Meisel, MD
Dr. Meisel is the director of the stroke clinic in the ambulatory care center. His interests are to provide a thorough evaluation of patients with a stroke from unclear causes (cryptogenic). He is working to use technology to achieve comprehensive care of patients after their acute stroke care. Dr. Meisel aims to use this care strategy to prevent future strokes and the related complications.